Advertising and promotion with European Pharmaceutical Review

European Pharmaceutical Review offers a variety of ways for you to promote your organisation, product or event. We provide bespoke advertising packages that deliver quantifiable results within your budget.

ABC audited, European Pharmaceutical Review is regularly distributed to 11,994* senior mangers and key decision-makers in the pharmaceutical, life-science and drug discovery industries predominantly across Europe, but also with a guaranteed circulation of 1,000 in the US. Typical readers are Managing Directors, Procurement Directors, Research Directors, Senior Scientists, Laboratory Managers, Process Engineers, Chief Engineers, Production Directors, Plant Managers, Product Managers, Quality Assurance Managers and Quality Control Managers. Pharmaceutical manufacturers are a core component of our readership, including Pfizer, Sanofi, Novartis, GlaxoSmithKline, AstraZeneca, Johnson & Johnson and Eli Lilly, amongst others.

Passed down through the management chain and distributed at industry events, we estimate that the total readership of European Pharmaceutical Review is 30,000 for each issue. This represents a highly targeted advertising opportunity for companies who wish to influence the key decision-makers in the industry.

For details of pricing, editorial features, readership, circulation and publication schedule, please download our print and digital media pack.

* Circulation of 11,994 is based on the 6 issues distributed between 1 January 2011 and 31 December 2011.